Telomere loss in cells treated with cisplatin
AUTOR(ES)
Ishibashi, Toru
FONTE
The National Academy of Sciences
RESUMO
Telomeres play an important role in the immortalization of proliferating cells. The long tandem repeats of 5′-TTAGGG-3′ sequences in human telomeres are potential targets for the anticancer drug cisplatin, which forms mainly intrastrand d(GpG) and d(ApG) cross-links on DNA. The present study reveals that telomeres in cisplatin-treated HeLa cells are markedly shortened and degraded. A dose that killed 61% of the cells but allowed one round of cell division resulted in shortened telomeres before the induction of apoptosis. Higher doses of cisplatin halted cell cycle progression during the first S phase and triggered apoptosis followed by degradation of telomere repeats. A model in which both cell division with incomplete replication and induction of apoptosis by cisplatin could occur was devised to explain the drug-induced telomere loss.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=22469Documentos Relacionados
- Hearing loss treated with pamidronate
- The rate of telomere sequence loss in human leukocytes varies with age
- Permanent loss of chromosome initiation in toluene-treated Bacillus subtilis cells.
- Repair of Chromosome Ends after Telomere Loss in Saccharomyces
- Acquired cisplatin resistance in human ovarian cancer cells is associated with enhanced repair of cisplatin-DNA lesions and reduced drug accumulation.
